Melanoma
Cancer journal article reports positive results in interferon alpha use in melanoma patients
Published in Medical Devices and Surgical Technology Week, July 23rd, 2006
The article, titled "Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha (Multiferon(R)): A controlled, randomized multicenter trial," reports positive results for a category of melanoma patients for whom prognosis is generally poor. The article concludes that the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices and Surgical Technology Week
More Articles from Medical Devices and Surgical Technology Week
- Cardiology
Systolic dysfunction and mild heart failure patients are treated with spironolactone - Electrocardiography
EASI-derived 12-lead electrocardiographic diagnoses are comparable to those from standard ECGs - Hairy Cell Leukemia
Clone-specific PCR assesses minimal residual disease in hairy cell leukemia - Medical Devices
Atrial septal defects of small-to-moderate diameter are best for closure with Helex septal occluder - Stem Cell Research
Galectin-1 promotes adult neural stem cell proliferation - Acne Treatment
MedSurge Advances' acne treatment process utilizes microdermabrasion, laser, cosmeceuticals - More from this issue of Medical Devices and Surgical Technology Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
